TP53BP1 and cancer: For example, among human SLFNs, only SLFN11 has been implicated in affecting cell fate decisions after cancer chemotherapy10, suggesting that only SLFN11 participates in the DNA damage response, though SLFN5 has recently been implicated in the 53BP1 topological regulation and non-homologous end joining27.